Peptides, miniature chains of protein building blocks, are gaining traction as a potent tool in pharmaceutical research. Their adaptability stems from their ability to mimic the body's inherent signaling components. This distinctive property facilitates targeted therapy for a broad range of diseases. From tumors to inflammatory disorders, peptides